Ingersoll Rand Investing Cash Flow increased by 17.8% to -$84.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 57.2%, from -$197.10M to -$84.40M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -10.5% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$25.00M | -$608.80M | -$188.40M | -$48.20M | -$17.30M | -$54.00M | -$217.80M | -$581.50M | -$73.90M | -$336.30M | -$68.80M | -$205.60M | -$2.63B | -$38.70M | -$234.90M | -$197.10M | -$82.30M | -$278.50M | -$102.70M | -$84.40M |
| QoQ Change | — | <-999% | +69.1% | +74.4% | +64.1% | -212.1% | -303.3% | -167.0% | +87.3% | -355.1% | +79.5% | -198.8% | <-999% | +98.5% | -507.0% | +16.1% | +58.2% | -238.4% | +63.1% | +17.8% |
| YoY Change | — | — | — | — | +30.8% | +91.1% | -15.6% | <-999% | -327.2% | -522.8% | +68.4% | +64.6% | <-999% | +88.5% | -241.4% | +4.1% | +96.9% | -619.6% | +56.3% | +57.2% |